tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

FOLD Stock Latest News

Amicus price target raised to $22 from $21 at UBS
The FlyAmicus price target raised to $22 from $21 at UBS
19d ago
FOLD
Amicus Positioned for Growth with Strategic Licensing and Promising FSGS Treatment
PremiumRatings
Amicus Positioned for Growth with Strategic Licensing and Promising FSGS Treatment
19d ago
FOLD
Amicus Therapeutics Reports Strong Q1 2025 Growth
PremiumCompany Announcements
Amicus Therapeutics Reports Strong Q1 2025 Growth
19d ago
FOLD
Amicus’s Strategic Positioning and Growth Potential Justify Buy Rating Despite Revenue Misses
PremiumRatings
Amicus’s Strategic Positioning and Growth Potential Justify Buy Rating Despite Revenue Misses
19d ago
FOLD
Amicus Therapeutics’ Earnings Call Highlights Growth and Strategic Moves
PremiumCompany Announcements
Amicus Therapeutics’ Earnings Call Highlights Growth and Strategic Moves
19d ago
FOLD
Amicus lowers FY25 total revenue growth view 15%-22% from 17%-24%
PremiumThe FlyAmicus lowers FY25 total revenue growth view 15%-22% from 17%-24%
20d ago
FOLD
Amicus reports Q1 non-GAAP EPS 3c, consensus 8c
Premium
The Fly
Amicus reports Q1 non-GAAP EPS 3c, consensus 8c
20d ago
FOLD
Amicus Secures License for DMX-200 Development
Premium
Company Announcements
Amicus Secures License for DMX-200 Development
20d ago
8K
FOLD
Amicus Therapeutics (FOLD) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Amicus Therapeutics (FOLD) Q1 Earnings Cheat Sheet
22d ago
FOLD
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ABVC
CMPX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
APRE
BCDA
Balanced Outlook on Amicus Therapeutics Amid Growth Ambitions and Market Challenges
PremiumRatings
Balanced Outlook on Amicus Therapeutics Amid Growth Ambitions and Market Challenges
2M ago
FOLD
Amicus Therapeutics: Strategic Market Expansion and Robust Sales Drive Buy Rating
PremiumRatingsAmicus Therapeutics: Strategic Market Expansion and Robust Sales Drive Buy Rating
3M ago
FOLD
Amicus Therapeutics Navigates Potential Risks Amid U.S. Trade Policy Changes
Premium
Company Announcements
Amicus Therapeutics Navigates Potential Risks Amid U.S. Trade Policy Changes
3M ago
FOLD
Amicus Therapeutics Shines with Strong Earnings Call
Premium
Company Announcements
Amicus Therapeutics Shines with Strong Earnings Call
3M ago
FOLD
Amicus Therapeutics Hold Rating: Balancing Growth Prospects with Investor Expectations
PremiumRatings
Amicus Therapeutics Hold Rating: Balancing Growth Prospects with Investor Expectations
3M ago
FOLD
Amicus price target lowered to $17 from $18 at Wells Fargo
PremiumThe Fly
Amicus price target lowered to $17 from $18 at Wells Fargo
3M ago
FOLD
Amicus’s Strategic Market Expansion and Strong Financial Outlook Drive Buy Rating
PremiumRatings
Amicus’s Strategic Market Expansion and Strong Financial Outlook Drive Buy Rating
3M ago
FOLD
Amicus Therapeutics Posts Robust 2024 Financial Growth
PremiumCompany Announcements
Amicus Therapeutics Posts Robust 2024 Financial Growth
3M ago
FOLD
Amicus Therapeutics: Promising Growth and Strong Financial Guidance Justify Buy Rating
PremiumRatingsAmicus Therapeutics: Promising Growth and Strong Financial Guidance Justify Buy Rating
3M ago
FOLD
Amicus files automatic mixed securities shelf
Premium
The Fly
Amicus files automatic mixed securities shelf
3M ago
FOLD
Amicus Stock: Fully Priced Amid Promising Growth and Hold Rating Recommendation
Premium
Ratings
Amicus Stock: Fully Priced Amid Promising Growth and Hold Rating Recommendation
3M ago
FOLD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >